A systematic review of flap fixation techniques in reducing seroma formation and its sequelae after mastectomy J. van BastelaarL. van RoozendaalY. Vissers Review 16 October 2017 Pages: 409 - 416
Clinical implications of germline mutations in breast cancer: TP53 Katherine SchonMarc Tischkowitz Review Open access 16 October 2017 Pages: 417 - 423
Ethnicity and breast cancer characteristics in Kenya Shahin SayedZahir MolooMansoor Saleh Preclinical study 26 September 2017 Pages: 425 - 437
Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models Yayoi AdachiMayumi YoshimuraHayao Nakanishi Preclinical study 12 October 2017 Pages: 439 - 450
The importance of early detection of calcifications associated with breast cancer in screening J. J. MordangA. Gubern-MéridaN. Karssemeijer Preclinical study Open access 17 October 2017 Pages: 451 - 458
Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance Jérôme AbadieFrédérique NguyenMario Campone Preclinical study Open access 23 October 2017 Pages: 459 - 468
Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer Thehang LuuKyu-pyo KimYun Yen Clinical trial 27 September 2017 Pages: 469 - 478
Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study O. Kaidar-PersonI. MeattiniT. Zagar Clinical trial 03 October 2017 Pages: 479 - 483
A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213. V. BernsteinS. L. EllardL. Seymour Clinical trial 13 October 2017 Pages: 485 - 493
Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery Bo Hwa ChoiNami ChoiHae Kyoung Jung Clinical trial 13 October 2017 Pages: 495 - 502
Correction to: Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery Bo Hwa ChoiNami ChoiHae Kyoung Jung Correction 14 November 2017 Pages: 503 - 503
Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials S. C. HayesM. L. SteeleE. Eakin Clinical trial 23 October 2017 Pages: 505 - 514
Correction to: Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials S. C. HayesM. L. SteeleE. Eakin Correction 10 November 2017 Pages: 515 - 515
Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark Deirdre Cronin-FentonAnders KjærsgaardHenrik T. Sørensen Epidemiology 25 September 2017 Pages: 517 - 528
Alcohol consumption across the life course and mammographic density in premenopausal women Ying LiuRulla M. TamimiKimberly A. Bertrand Epidemiology 26 September 2017 Pages: 529 - 535
Predictors of the quality of life in Chinese breast cancer survivors Juan XiaZheng TangJinming Yu Epidemiology 30 September 2017 Pages: 537 - 545
Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impact David B. PageHannah WenHeather L. McArthur Epidemiology 06 October 2017 Pages: 547 - 554
Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt Laura S. DominiciHelmneh M. SineshawRachel A. Freedman Epidemiology 09 October 2017 Pages: 555 - 566
Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study Thomas FietzMark-Oliver Zahnthe TMK-Group (Tumour Registry Breast Cancer) Epidemiology Open access 13 October 2017 Pages: 567 - 578
Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010 Judith A. MalmgrenMusa MayerHenry G. Kaplan Epidemiology Open access 16 October 2017 Pages: 579 - 590
Serum selenium levels predict survival after breast cancer J. LubinskiW. MarciniakS. A. Narod Epidemiology 17 October 2017 Pages: 591 - 598
Questions about Ki67 staining in luminal breast cancer Kadri Altundag Letter to the Editor 27 September 2017 Pages: 599 - 599
Response letter to: Questions about Ki67 staining in luminal breast cancer Alberto GallardoEnrique Lerma Rebuttal Letter 27 September 2017 Pages: 601 - 601
A need for biology-driven personalized radiotherapy in breast cancer Pelagia G. TsoutsouAndré-Dante DurhamMarie-Catherine Vozenin Brief Report 27 September 2017 Pages: 603 - 604
Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer Muhammad AsaduzzamanStephanie ConstantinouErnesto Yagüe Correction 05 January 2018 Pages: 605 - 606